About BioCat
BioCat is a company based in Heidelberg (Germany) founded in 2000 was acquired by AddLife in April 2022. The company has 19 employees. BioCat operates in a competitive market with competitors including Abcam, Inscripta, Stem Cell Technologies, GenScript and OncoDNA, among others.
- Headquarter Heidelberg, Germany
- Employees 19
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biocat.com
- Social LinkedIn Facebook
- Acquired by AddLife (Apr 2022)
- Legal Name Biocat Gmbh
Investors in BioCat
BioCat has secured backing from 1 investor. Prominent investors backing the company include AddLife.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of drugs for multiple therapeutic areas | 2015 | add.life | Stockholm, Sweden |
Investor details for BioCat
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BioCat
2 dated milestones of BioCat across 22 years, from founding to its latest funding, stage changes and deals.
- Founded BioCat is founded.
- Exit Acquired by AddLife.
Competitors of BioCat
BioCat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Inscripta, Stem Cell Technologies, GenScript and OncoDNA, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| inscripta.io | 2015 | Helsinki, Finland | $853,384 | – | Speech recognition solutions are provided by Inscripta for healthcare professionals. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| oncodna.com | 2012 | Charleroi, Belgium | $44.53M | 37 | Genomic and theranostic services for oncology precision medicine are delivered. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application | |
| diagenode.com | 2003 | Seraing, Belgium | $8.45M | 99 | Reagents and kits for epigenetics sequencing solutions are developed. | |
| fluentbio.com | 2018 | Watertown, United States | $19M | – | Proprietary reagents for single-cell genetic analysis are developed. | |
| devyser.com | 2004 | Stockholm, Sweden | $15.48M | – | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders |
Detailed competitors of BioCat
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioCat
The website of BioCat (biocat.com) receives about 37.9K visits a month.
- Monthly visits37.9K
▼ 6.9% vs previous month
Websites whose visitors overlap most with BioCat. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
promega.com | promega.com | 100% | – | #192,389 | – |
| bioscience.co.uk | 98% | 58K | #534,137 | View details | |
| clontech.com | 94% | – | – | View details | |
| biochain.com | 91% | 20.6K | #1,374,754 | View details | |
abmole.com | abmole.com | 87% | – | #940,860 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for BioCat
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Biocat
Complete news archive for BioCat
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to BioCat
10 companies that operate in the same segment as BioCat (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioCat
BioCat was founded in 2000.
BioCat is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
BioCat has 19 employees.
Provider molecular biology reagents and technologies for research purposes. The product portfolio of the company includes CRISPR Cas9 cDNA, ORF, shRNA, gRNA, antibodies, ELISA Kits, proteins, cell-based assays, metabolism assays, microRNA analysis, epigenetics, PCR, cloning, viral systems, tissue-specific analysis, and more. It offers custom services in gene synthesis, gRNA synthesis, qPCR primersprobes, exosome RNA, NGS, gRNA, cloning shRNA cloning, lentiviral packaging, and peptide synthesis.
BioCat's top competitors include Abcam, Sino Biological and OncoDNA.
BioCat has 1 investor. Key investors include AddLife.
BioCat operates through Biocat Gmbh.
Yes. BioCat was acquired by AddLife in April 2022.